Showing results (541-550 of 1,340) with videos related to
Sort By:
Pageof 134
Neuro-Oncology Advances|July 3, 2024
Comparative evaluation of the diagnostic and prognostic performance of CNSide™ versus standard cytology for leptomeningeal diseaseHaley R Appel, Muni Rubens, Mukesh Roy, et al.Neuro-Oncology Advances|July 1, 2024
Longitudinal assessment of quality of life, neurocognition, and psychopathology in patients with low-grade glioma on first-line temozolomide: A feasibility studyAmélie Darlix, Maëva Monnier, Florence Castan, et al.Neuro-Oncology Advances|July 4, 2024
Clinical utility of DNA methylation profiling for choroid plexus tumorsKee Kiat Yeo, Cassie B Macrae, Bradley Gampel, et al.Neuro-Oncology Advances|July 4, 2024
Evidence for inflammation in normal-appearing brain regions in patients with growing sporadic vestibular schwannoma: A PET studyBandar Alfaifi, Rainer Hinz, Alan Jackson, et al.Neuro-Oncology Advances|August 30, 2024
Durable benefit and slowdown in tumor growth dynamics with erdafitinib in a FGFR3-TACC3 fusion-positive IDH-wild type glioblastomaSantiago Cabezas-Camarero, Rebeca Pérez-Alfayate, Carmen Polidura, et al.Neuro-Oncology Advances|August 19, 2024
Directionally non-rotating electric field therapy delivered through implanted electrodes as a glioblastoma treatment platform: A proof-of-principle studyJun Ma, Shilpi Singh, Ming Li, et al.Neuro-Oncology Advances|June 21, 2024
Fibroblast growth factor receptor 1 gene mutation as a potential risk factor for spontaneous intracranial hemorrhage in pediatric low-grade glioma patientsMaxine Gonzalez-Vega, Brittany M Lebert, Stephani Campion, et al.Neuro-Oncology Advances|April 29, 2024
[11C]-methionine positron emission tomography in the evaluation of pediatric low-grade gliomasEmily Y Kim, Amy L Vavere, Scott E Snyder, et al.Neuro-Oncology Advances|May 30, 2024
TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive gliomaAlberto Picca, Anna Luisa Di Stefano, Julien Savatovsky, et al.Neuro-Oncology Advances|June 10, 2024
Leveraging murine models of the neurofibromatosis type 1 cancer predisposition syndrome to elucidate the cellular circuits that drive pediatric low-grade glioma formation and progressionDavid H GutmannPageof 134